Anick F. Dubois

5000 Belanger St
Montreal, QC H1T1C8, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Bayesian Reanalysis of Mortality Outcomes in Cardiovascular Trials: Addressing Limitations of Traditional Significance Testing.

Bayesian Reanalysis of Mortality Outcomes in Cardiovascular Trials: Addressing Limitations of Traditional Significance Testing.

Journal: Journal of cardiovascular translational research

Published: July 30, 2025

Effect of probiotic supplementation on glycemic control in patients with type 2 diabetes: A randomized controlled trial.

Effect of probiotic supplementation on glycemic control in patients with type 2 diabetes: A randomized controlled trial.

Journal: Clinical nutrition ESPEN

Published: April 19, 2025

Overcoming barriers to implementation of patient engagement in clinical trials: feasibility testing of an embedded study.

Overcoming barriers to implementation of patient engagement in clinical trials: feasibility testing of an embedded study.

Journal: Research involvement and engagement

Published: October 31, 2024

A Cost-Effectiveness Analysis of Biomarkers for Risk Prediction in Atrial Fibrillation.

A Cost-Effectiveness Analysis of Biomarkers for Risk Prediction in Atrial Fibrillation.

Journal: Molecular diagnosis & therapy

Published: January 11, 2023

Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial.

Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial.

Journal: The Lancet. Respiratory medicine

Published: March 16, 2021

Genetics of symptom remission in outpatients with COVID-19.

Genetics of symptom remission in outpatients with COVID-19.

Journal: Scientific reports

Published: March 02, 2021

Pharmacogenomics of the Efficacy and Safety of Colchicine in COLCOT.

Pharmacogenomics of the Efficacy and Safety of Colchicine in COLCOT.

Journal: Circulation. Genomic and precision medicine

Published: February 09, 2021

VIVOPTIM: Feedback of an e-Health experimental program of primary prevention of cardiovascular risk on 30 to 70 years old volunteers

VIVOPTIM: Feedback of an e-Health experimental program of primary prevention of cardiovascular risk on 30 to 70 years old volunteers

Journal: Annales de cardiologie et d'angeiologie

Published: September 06, 2018

A Discrete Event Simulation Model to Assess the Economic Value of a Hypothetical Pharmacogenomics Test for Statin-Induced Myopathy in Patients Initiating a Statin in Secondary Cardiovascular Prevention.

A Discrete Event Simulation Model to Assess the Economic Value of a Hypothetical Pharmacogenomics Test for Statin-Induced Myopathy in Patients Initiating a Statin in Secondary Cardiovascular Prevention.

Journal: Molecular diagnosis & therapy

Published: April 14, 2018

A model to assess the cost-effectiveness of pharmacogenomics tests in chronic heart failure: the case of ivabradine.

A model to assess the cost-effectiveness of pharmacogenomics tests in chronic heart failure: the case of ivabradine.

Journal: Pharmacogenomics

Published: October 11, 2016

Maximal expected benefits from lowering cholesterol in primary prevention for a high-risk population.

Maximal expected benefits from lowering cholesterol in primary prevention for a high-risk population.

Journal: Current medical research and opinion

Published: September 21, 2016

Whole-genome sequencing in French Canadians from Quebec.

Whole-genome sequencing in French Canadians from Quebec.

Journal: Human genetics

Published: April 12, 2016

Showing 1-12 of 14

Last Updated: 09/26/2026